Posts

BGB-10188 by BeiGene for Epithelial Ovarian Cancer: Lik...

BGB-10188 is under clinical development by BeiGene and currently in Phase II for...

Rhenium (186Re) obisbemeda by Plus Therapeutics for Hea...

Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...

Rhenium (186Re) obisbemeda by Plus Therapeutics for Tri...

Rhenium (186Re) obisbemeda is under clinical development by Plus Therapeutics an...

PBCAR-19B by Precision Biosciences for Mantle Cell Lymp...

PBCAR-19B is under clinical development by Precision Biosciences and currently i...

DF-003 by Drug Farm for Chronic Kidney Disease (Chronic...

DF-003 is under clinical development by Drug Farm and currently in Phase I for C...

(CST-2032 + nadolol) by CuraSen Therapeutics for Dement...

(CST-2032 + nadolol) is under clinical development by CuraSen Therapeutics and c...

An Ask Me Anything with STAT’s Nicholas St. Fleur

Read an Ask Me Anything with STAT’s Nicholas St. Fleur: his favorite parts of th...

STAT+: Biden administration proposes fixes to No Surpri...

The proposal aims to increase early communication between insurers and providers...

Senate committee plans Nov. 8 vote on wide-ranging heal...

The Senate Finance Committee plans to move ahead with a wide-ranging health care...

Paying for Covid pills will soon shift to insurers

The Biden administration is slowly shifting millions of Covid-19 treatments to p...

STAT+: FDA has some safety concerns about CRISPR-based ...

The FDA said it has some safety concerns about an experimental CRISPR-based trea...

STAT+: Why Sanofi got shellacked

Sanofi, the Paris-based drug giant, announced that it would spin out its $5 bill...

STAT+: Up and Down the Ladder: The latest comings and g...

From new hires to departures, transfers and promotions, here are the latest comi...

Regeneron gene therapy improves hearing in child

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Sanofi plans to spin off its consu...

The European Medicines Agency disclosed that its safety panel did not find a cau...

STAT+: In major test for prime editing, scientists succ...

Prime Medicine says its refinement of CRISPR passed the major test of correcting...